Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis.
Data on invasive mold infections (IMIs) after chimeric antigen receptor T-cell (CAR-T) therapy are limited. We describe two patients with post-CAR-T-cell IMI (Fusarium, Mucorales) and review the published literature. We propose strategies to prevent IMIs in these patients, based on the IMI rate and presence of neutropenia or steroid use.